You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HS-20093

Showing 26 - 50 of 549
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial (HS-10502)

Not yet recruiting
  • Ovarian Cancer
  • +4 more
  • (no location specified)
Feb 24, 2023

Type 2 Diabetes Trial in Beijing (HS-20094 5mg, HS-20094 10mg, HS-20094 15mg)

Recruiting
  • Type 2 Diabetes
  • HS-20094 5mg
  • +3 more
  • Beijing, Beijing, China
    Peking University First Hospital
Nov 3, 2023

Endometriosis Trial (HS-10518, Placebo)

Not yet recruiting
  • Endometriosis
  • (no location specified)
Nov 1, 2023

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Beijing (HS-20089)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • Beijing, Beijing, China
    Lingying Wu
Aug 22, 2023

Psoriasis Trial in Shanghai (HS-10374 tablets, HS-10374-matched tablets)

Completed
  • Psoriasis
  • HS-10374 tablets
  • HS-10374-matched placebo tablets
  • Shanghai, Shanghai, China
    Huashan Hospital Affiliated to Fudan University
Sep 5, 2023

Vasomotor Symptoms Trial in Peking (HS-10384 tablets, HS-10384-matched tablets)

Not yet recruiting
  • Vasomotor Symptoms
  • HS-10384 tablets
  • HS-10384-matched placebo tablets
  • Peking, Beijing, China
    Peking University Third Hospital
Nov 7, 2023

Type 2 Diabetes Trial in Beijing (HS-20094, Placebo)

Recruiting
  • Type 2 Diabetes
  • Beijing, Beijing, China
    Beijing University First Hospital
Jul 18, 2022

Healthy Trial (HS-10506, HS-10506 Placebo)

Not yet recruiting
  • Healthy
  • (no location specified)
Jul 12, 2023

Hidradenitis Suppurativa (HS) Trial in Lyon (Skin Swab & Skin Biopsies & Blood Sample)

Not yet recruiting
  • Hidradenitis Suppurativa (HS)
  • Skin Swab & Skin Biopsies & Blood Sample
  • Lyon, Rhône, France
    Department of Dermatology-Hôpital Edouard Herriot
Feb 9, 2023

Hidradenitis Suppurativa Trial in Little Rock (Mindfulness Based Stress reduction)

Recruiting
  • Hidradenitis Suppurativa
  • Mindfulness Based Stress reduction
  • Little Rock, Arkansas
    UAMS Dermatology Clinic
Nov 2, 2023

IgA Nephropathy, Focal Segmental Glomerulosclerosis Trial in Nanjing (HS-10390 tablet, Placebo tablet)

Recruiting
  • IgA Nephropathy
  • Focal Segmental Glomerulosclerosis
  • HS-10390 tablet
  • Placebo tablet
  • Nanjing, Jiangsu, China
    Zhongda Hospital, Affiliated to Southeast University
Jul 12, 2023

Cough Trial in Jinan (HS-10383, HS-10383 Placebo)

Recruiting
  • Cough
  • Jinan, Shandong, China
    Shandong provincial qianfoshan hospital
Oct 19, 2023

Schizophrenia Trial (HS-10380, Placebo)

Not yet recruiting
  • Schizophrenia
  • (no location specified)
Jul 19, 2023

Tumor, Solid Tumors Trial in Camperdown, Liverpool (HS-10241)

Completed
  • Neoplasm
  • Solid Tumors
  • Camperdown, New South Wales, Australia
  • +1 more
Jul 18, 2022

Abbott i-STAT High Sensitivity Troponin I Study

Enrolling by invitation
  • Myocardial Infarction
  • i-STAT hs-TnI Cartridge Testing on i-STAT 1 and i-STAT Alinity
  • Chandler, Arizona
  • +3 more
Dec 21, 2022

Hidradenitis Suppurativa Trial in San Francisco

Recruiting
  • Hidradenitis Suppurativa
    • San Francisco, California
      University of California, San Francisco
    Jun 2, 2022

    Hidradenitis Suppurativa Trial in Miami (Home Exercise Program, Short Exercise Program)

    Not yet recruiting
    • Hidradenitis Suppurativa
    • Home Exercise Program
    • Short Exercise Program
    • Miami, Florida
      University of Miami
    Aug 23, 2023

    Alopecia, Chemo-Induced Change, Hair Loss Trial in Tucson (Keratinocyte growth factor)

    Completed
    • Alopecia
    • +3 more
    • Keratinocyte growth factor
    • Tucson, Arizona
      University of Arizona
    Dec 15, 2022

    The Disease Severity In Patients With Psoriasis

    Completed
    • Psoriasis
      • Sukoharjo, Central Java, Indonesia
        Universitas Sebelas Maret Hospital
      Jul 4, 2023

      Postpartum Depression Trial (HS-10353 Capsules 30 mg, Oral, QN for 14 days, HS-10353 Capsules 50 mg, Oral, QN for 14 days,

      Not yet recruiting
      • Postpartum Depression
      • HS-10353 Capsules 30 mg, Oral, QN for 14 days
      • +3 more
      • (no location specified)
      Jul 2, 2023

      Hidradenitis Suppurativa Trial in Worldwide (Lutikizumab, Placebo)

      Recruiting
      • Hidradenitis Suppurativa
      • Lutikizumab
      • Placebo
      • Phoenix, Arizona
      • +54 more
      Jan 26, 2023

      COVID-19 Trial in Jinan (HS-10517 Dose 1, HS-10517 Dose 2, HS-10517 Dose 3)

      Recruiting
      • COVID-19
      • HS-10517 Dose 1
      • +4 more
      • Jinan, Shandong, China
        The First Affiliated Hospital of Shandong First Medical Universi
      Mar 9, 2023

      Hidradenitis Suppurativa Trial in Bronx (Intralesional Triamcinolone 10 mg/mL, Intralesional Triamcinolone 20 mg/mL,

      Terminated
      • Hidradenitis Suppurativa
      • Intralesional Triamcinolone 10 mg/mL
      • +3 more
      • Bronx, New York
        Steven Cohen
      Nov 10, 2022

      Advanced Solid Tumor Trial in Shanghai (HS-10386)

      Recruiting
      • Advanced Solid Tumor
      • Shanghai, Shanghai, China
        Shanghai Chest Hospital
      Jun 20, 2023

      Advanced or Metastatic NSCLC Trial in Guangzhou (HS-10375)

      Recruiting
      • Advanced or Metastatic NSCLC
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Jun 27, 2022